Abstract
The etiology of interstitial cystitis/bladder pain syndrome (IC/BPS) has been described as related to inflammation, mucosal defects, permeability problems, neuro-endocrine abnormalities, genetic disturbances, and/or infection, but the end result becomes a hypersensitivity of the urinary bladder with hallmarks that include exaggerated and abnormal sensory and motor reactions to the presence of urine in the bladder. In some patients, the symptoms progress to debilitating hyperalgesia and allodynia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185:2162.
Taneja R. Intravesical lignocaine in the diagnosis of bladder pain syndrome. Int Urogynecol J. 2010;21(3):321–4.
Hanno PM. Bladder pain syndrome (interstitial cystitis) and related disorders (Chapter 12). In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 10th ed. Philadelphia, PA: Saunders; 2012.
Riley J, Boulis N. Molecular mechanisms of pain: a basis for chronic pain and therapeutic approaches based on the cell and the gene. Clin Neurosurg. 2006;53:77–97.
Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev. 1972;24:583–655.
Yanagi H, Sankawa H, Saito H, Iikura Y. Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and basophils. Acta Anaesthesiol Scand. 1996;40:1138–44.
Butrick CW. Interstitial cystitis/bladder pain syndrome: management of the pain disorder: a urogynecology perspective. Urol Clin North Am. 2012;39:377–87.
Scott DB. Toxic effects of local anesthetic agents on the central nervous system. Br J Anaesth. 1986;58:732–5.
Tucker GT, Mather LE. Properties, absorption, and disposition of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, Neural ED, editors. Blockage in clinical anesthesia and management of pain. Philadelphia, PA: Lippincott-Raven; 1998. p. 55–86.
Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med. 2012;37(1):16–8.
Birch BR, Miller RA. Absorption characteristics of lignocaine following intravesical instillation. Scand J Urol Nephrol. 1994;28:359.
Henry R, Patterson L, Avery N, et al. Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J Urol. 2001;165:1900.
Pode D, Zylber-Katz E, Shapiro A. Intravesical lidocaine: topical anesthesia for bladder mucosal biopsies. J Urol. 1992;148:795.
Thrasher JB, Kreder KJ, Peterson NE, et al. Lidocaine as topical anesthesia for bladder mappings and cold-cup biopsies. J Urol. 1993;150:335.
Asklin B, Cassuto J. Intravesical lidocaine in severe interstitial cystitis. Case report. Scand J Urol Nephrol. 1989;23:311–2.
Giannakopoulos X, Champilomatos P. Chronic interstitial cystitis. Successful treatment with intravesical lidocaine. Arch Ital Urol Nefrol Androl. 1992;64(4):337–9.
Quillin RB, et al. Practical use of the new american urological association interstitial cystitis guidelines. Curr Urol Rep. 2012;13(5):394–401.
Moldwin R, Brettschneider N. The use of intravesical anesthetics to aid in the diagnosis of interstitial cystitis. Presented at research insights into interstitial cystitis: a basic and clinical science forum, Alexandria, VA, 31 Oct 2003, poster 41.
Lukban JC, Whitmore KE, Sant GR. Current management of interstitial cystitis. Urol Clin North Am. 2002;29:649.
Henry R, Morales A, Cahill C. Beyond a simple anesthetic effect: lidocaine in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Urology. 2015;85:1025–33.
Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103:910–8.
Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996;156:45–8.
Engelhardt PF, Morakis N, Daha LK, Esterbauer B, Riedl CR. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2011;22(4):401–5.
Lv YS, Zhou HL, Mao HP, et al. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis. Int Urogynecol J. 2012;23:1715–20.
Davis EL, El Khoudary SR, Talbott EO, et al. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179:177.
Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73:504–7.
Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65:45–8.
Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology. 2008;71:67–70.
Nomiya A, Naruse T, Niimi A, et al. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol. 2013;20:1118–22.
Parsons CL, Zupkas P, Proctor J, et al. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J Sex Med. 2012;9:207–12.
Nickel JC, Jain P, Shore N, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 2014;4:143100.
Fontanella UA, Rossi CA, Stephen RL. Iontophoretic local anaesthesia for bladder dilatation in the treatment of interstitial cystitis. Br J Urol. 1992;69:662–3.
Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8:142–5.
Riedl CR, Knoll M, Plas E, Pfluger H. Electromotive drug administration and hydrodis-tention for the treatment of interstitial cystitis. J Endourol. 1998;12:269–72.
Rose AE, Payne CK, Azevedo K. Pilot study of the feasibility of in-office bladder distention using electromotive drug adminstration (EMDA). Neurourol Urodyn. 2005;24:254–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Golda, N., Nickel, J.C. (2017). Intravesical Lidocaine in Interstitial Cystitis/Bladder Pain Syndrome. In: Moldwin, R. (eds) Urological and Gynaecological Chronic Pelvic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-48464-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-48464-8_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48462-4
Online ISBN: 978-3-319-48464-8
eBook Packages: MedicineMedicine (R0)